
IPHA
Healthcare · Biotechnology · $154.1M market cap
$1.38-0.11 (-7.4%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -8.7% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.15 | — | — |
| May 13, 2026 | Before the open | -0.16 | 0.00 | +100.0% |
| Nov 13, 2025 | Before the open | -0.14 | -0.14 | -1.6% |
| Sep 17, 2025 | Time not confirmed | — | -0.30 | — |
| Apr 30, 2025 | Time not confirmed | -0.40 | -0.30 | +25.0% |
| Mar 27, 2025 | Time not confirmed | -0.40 | -0.30 | +25.0% |
| Nov 13, 2024 | Time not confirmed | — | 0.00 | — |
| Sep 12, 2024 | Time not confirmed | -0.38 | -0.31 | +19.4% |
| May 14, 2024 | Before the open | 0.00 | 0.00 | — |
| Mar 21, 2024 | Before the open | -0.41 | -0.12 | +71.9% |
| Nov 14, 2023 | Time not confirmed | — | 0.00 | — |
| Sep 14, 2023 | Time not confirmed | -0.14 | 0.02 | +114.6% |
| May 10, 2023 | Time not confirmed | — | 0.00 | — |
Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma; IPH4502, a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan…
| Mar 23, 2023 | Time not confirmed | -0.39 | 0.00 | +100.0% |
| Nov 14, 2022 | Time not confirmed | — | 0.00 | — |
| Sep 15, 2022 | Time not confirmed | -0.08 | 0.00 | +100.0% |
| Apr 3, 2022 | After the close | -0.17 | -0.16 | +5.9% |
| Mar 24, 2022 | Time not confirmed | — | -0.66 | — |
| Nov 16, 2021 | Time not confirmed | — | 0.00 | — |
| Sep 15, 2021 | Time not confirmed | — | 0.00 | — |
| Apr 26, 2021 | After the close | 0.05 | -0.18 | -460.0% |
| Mar 18, 2021 | Before the open | -0.09 | -0.18 | -95.6% |
| Nov 17, 2020 | Before the open | -0.09 | -0.09 | 0.0% |
| Sep 8, 2020 | Before the open | -0.08 | -0.08 | -3.4% |
| May 12, 2020 | Before the open | 0.00 | -0.07 | — |
| Mar 10, 2020 | Before the open | -0.18 | -0.18 | 0.0% |
| Nov 13, 2019 | Before the open | -0.09 | 0.04 | +149.4% |
| Sep 13, 2019 | Before the open | -0.09 | -0.09 | +1.8% |
| May 15, 2019 | Before the open | 0.00 | 0.00 | — |
| Nov 15, 2018 | Time not confirmed | — | 0.08 | — |